Solid Tumors Clinical Trials

There are 16 registered clinical trials for Solid Tumors in the TrialLens index.

Trials (16)

• Exploring the Clinical Value of RT01-89Zr PET Imaging in Solid Tumors Early Phase 1 · Nanolattix Biotechnology Co., Ltd.
• Expanded Access Program for Avapritinib N/A · Blueprint Medicines Corporation
• Dose Escalation and Pharmacokinetic Study of Paclitaxel Liposome Injection in Treating Patients With Advanced Solid Tumor After Failure From Conventional Treatments Phase 4 · Nanjing Luye Sike Pharmaceutical Co., Ltd.
• Collection of Pharmacokinetic Samples From People With Unanticipated Response, Significant Toxicity or Concern of Future Toxicity N/A · National Cancer Institute (NCI)
• A Trial of Gefitinib in Combination With BKM120 in Patients With Advanced Non-Small Cell Lung Cancer, With Enrichment for Patients Whose Tumours Harbour Molecular Alterations of PI3K Pathway and Known to Overexpress EGFR Phase 1 · National Cancer Centre, Singapore
• A Study of Intravenous (IV) Cergutuzumab Amunaleukin and Atezolizumab in Combination in Participants With Locally Advanced and/or Metastatic Solid Tumors Phase 1 · Hoffmann-La Roche
• Efficacy and Safety Study of Multiple Doses of IMAB362 in Patients With Advanced Gastroesophageal Cancer Phase 2 · Ganymed Pharmaceuticals GmbH
• CDDO to Treat Solid Tumors and Lymphomas Phase 1 · National Cancer Institute (NCI)
• Study of the Effects of Pre-surgical Aerobic Exercise on Patients With Solid Tumors Early Phase 1 · Memorial Sloan Kettering Cancer Center
• Biomarkers for Prediction of Tumor Response to Radiotherapy N/A · Chuangzhen Chen
• Phase 1 Study of IBR854 in Locally Advanced Or Metastatic Solid Tumors Phase 1 · Imbioray (Hangzhou) Biomedicine Co., Ltd.
• A Clinical Study of 9MW2821 Monotherapy or Combined With Other Anticancer Therapy in Advanced Solid Tumors Phase 1/2 · Mabwell (Shanghai) Bioscience Co., Ltd.
• A Dose Escalation Study of OMP-54F28 in Subjects With Solid Tumors Phase 1 · OncoMed Pharmaceuticals, Inc.
• Phase 1 Study Of Aurora Kinase Inhibitor PF-03814735 In Patients With Advanced Solid Tumors Phase 1 · Pfizer
• A I/II Phase Clinical Study to Evaluate the Safety and Efficacy of RC288 in the Treatment of Solid Tumors Phase 1/2 · RemeGen Co., Ltd.
• An Exploratory Study of Zanidatamab in HER2-positive Advanced Tumor After at Least One Line of Standard Therapy Phase 2 · Haihua Yuan

Related landscapes

• Phase 4 Solid Tumors
• Phase 1/2 Solid Tumors
• Phase 2 Solid Tumors
• N/A Solid Tumors
• Early Phase 1 Solid Tumors

Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.